A clinical trial of a new lung cancer drug called Keytruda was halted because it's so effective that researchers want to offer it to all the patients in the study.
Response rate doubled for patients with this blood cancer, study finds
Experimental approach doubles time to disease progression, experts find
Cancer is entering a "new era" of personalised medicine with drugs targeted to the specific weaknesses in each patient's tumour, say doctors.
RIYADH: A research team headed by professor Khawla Al-Kuraya at the King Faisal Specialist Hospital and Research Center (KFSH) has published a landmark paper that provides many novel insights into the inner working of thyroid cancer.
Lifestyle may matter even more when your DNA is working against you, research showsWomen who carry common gene variants linked to breast cancer can still cut their risk of the disease by following a healthy lifestyle, a large new study suggests.
But study found just 30 minutes of exercise a week might lower chances of disease
LONDON – A second baby with aggressive leukemia has been treated in London with "designer immune cells" developed by Cellectis and, six months after treatment, she remains in remission, the French biotech firm said on Friday.
Neither extra chemotherapy drug nor add-on radiation aided longevity in French trial
Scientists say they now have a near-perfect picture of the genetic events that cause breast cancer.
